Health and Healthcare

Amgen : AMGN

All Amgen Articles

717 Articles

Chris Lange | Jan 28, 2020 at 8:45 AM EST

Short Sellers Wary on Major Biotechs

The January 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jan 26, 2020 at 7:10 AM EST

Amazon, Facebook, Starbucks, Tesla and More Major Earnings Coming This Week

24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including Amazon.com, AT&T and…

Chris Lange | Jan 23, 2020 at 1:35 PM EST

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.

Chris Lange | Jan 13, 2020 at 8:40 AM EST

Major Biotechs Have Short Sellers Excited

The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech…

Chris Lange | Dec 26, 2019 at 8:40 AM EST

Major Biotechs See Rising Short Interest

The December 13 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Dec 24, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron, Sarpeta and More

Christmas Eve's top analyst upgrades, downgrades and initiations included Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron Pharmaceuticals…

Paul Ausick | Dec 24, 2019 at 7:55 AM EST

Allergan Gets FDA Approval for Migraine Treatment

The FDA has approved Allergan's treatment for migraines in adults. The drug is the first of its class to obtain…

Jon C. Ogg | Dec 16, 2019 at 10:55 AM EST

Goldman Sachs Has 3 Top Health Care Stocks to Outperform in 2020

Goldman Sachs believes that several health care companies can win, and it has three top picks for 2020 that may…

Jon C. Ogg | Dec 16, 2019 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Adobe, Amgen, BofA, Broadcom, CME, Goldman Sachs, Micron, PepsiCo, UnitedHealth, Urban Outfitters, Vertex and More

Monday's top analyst upgrades, downgrades and initiations included Adobe, Amgen, Bank of America, Broadcom, CME, Goldman Sachs, Micron Technology, PepsiCo,…

Chris Lange | Dec 11, 2019 at 9:10 AM EST

Major Biotechs See a Rising Tide in Short Interest

The November 29 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Nov 27, 2019 at 8:40 AM EST

Short Sellers Run For Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The November 15 short interest data…

Chris Lange | Nov 12, 2019 at 10:00 AM EST

Major Biotechs See Rising Tide in Short Interest

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data…

Jon C. Ogg | Nov 12, 2019 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva…

Jon C. Ogg | Nov 5, 2019 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Amgen, Beyond Meat, Cisco, Home Depot, Microsoft, RingCentral, Shake Shack, Tilray, Uber, Under Armour, US Steel and More

Tuesday's top analyst upgrades, downgrades and initiations included Amgen, Beyond Meat, Cisco, Home Depot, Microsoft, RingCentral, Shake Shack, Tilray, Uber,…

Chris Lange | Oct 29, 2019 at 4:20 PM EDT

Why Amgen Failed to Impress in Q3

When Amgen released its third-quarter financial results after the markets closed on Tuesday, the firm said that it had $3.66…

1 … 11 12 13 14 15 … 48

Amgen : AMGN

All Amgen Articles

Short Sellers Wary on Major Biotechs

Amazon, Facebook, Starbucks, Tesla and More Major Earnings Coming This Week

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Major Biotechs Have Short Sellers Excited

Major Biotechs See Rising Short Interest

Top Analyst Upgrades and Downgrades: Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron, Sarpeta and More

Allergan Gets FDA Approval for Migraine Treatment

Goldman Sachs Has 3 Top Health Care Stocks to Outperform in 2020

Top Analyst Upgrades and Downgrades: Adobe, Amgen, BofA, Broadcom, CME, Goldman Sachs, Micron, PepsiCo, UnitedHealth, Urban Outfitters, Vertex and More

Major Biotechs See a Rising Tide in Short Interest

Short Sellers Run For Cover From Major Biotechs

Major Biotechs See Rising Tide in Short Interest

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Top Analyst Upgrades and Downgrades: Amgen, Beyond Meat, Cisco, Home Depot, Microsoft, RingCentral, Shake Shack, Tilray, Uber, Under Armour, US Steel and More

Why Amgen Failed to Impress in Q3

Arizonans Don’t Retire in Scottsdale. Here’s Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Two Latin Words on Your Beneficiary Form Decide Whether Your Grandchildren Inherit Their Late Parent’s Share or Watch It Get Split Among the Aunts and Uncles

Arizonans Don't Retire in Scottsdale. Here's Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Arizonans Don’t Retire in Scottsdale. Here’s Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Amgen : AMGN

All Amgen Articles

Short Sellers Wary on Major Biotechs

Amazon, Facebook, Starbucks, Tesla and More Major Earnings Coming This Week

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Major Biotechs Have Short Sellers Excited

Major Biotechs See Rising Short Interest

Top Analyst Upgrades and Downgrades: Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron, Sarpeta and More

Allergan Gets FDA Approval for Migraine Treatment

Goldman Sachs Has 3 Top Health Care Stocks to Outperform in 2020

Top Analyst Upgrades and Downgrades: Adobe, Amgen, BofA, Broadcom, CME, Goldman Sachs, Micron, PepsiCo, UnitedHealth, Urban Outfitters, Vertex and More

Major Biotechs See a Rising Tide in Short Interest

Short Sellers Run For Cover From Major Biotechs

Major Biotechs See Rising Tide in Short Interest

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Top Analyst Upgrades and Downgrades: Amgen, Beyond Meat, Cisco, Home Depot, Microsoft, RingCentral, Shake Shack, Tilray, Uber, Under Armour, US Steel and More

Why Amgen Failed to Impress in Q3

Arizonans Don’t Retire in Scottsdale. Here’s Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Two Latin Words on Your Beneficiary Form Decide Whether Your Grandchildren Inherit Their Late Parent’s Share or Watch It Get Split Among the Aunts and Uncles

Featured Reads

Arizonans Don't Retire in Scottsdale. Here's Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.